Article Versions Notes

Ribaldone DG, Adriani A, Caviglia GP, De Nicolò A, Agnesod D, Simiele M, Riganò D, Pellicano R, Canaparo R, Di Perri G, et al. Correlation between Thiopurine S-Methyltransferase Genotype and Adverse Events in Inflammatory Bowel Disease Patients. Medicina. 2019; 55(8):441. https://doi.org/10.3390/medicina55080441

Ribaldone, Davide Giuseppe, Alessandro Adriani, Gian Paolo Caviglia, Amedeo De Nicolò, Danilo Agnesod, Marco Simiele, Danila Riganò, Rinaldo Pellicano, Roberto Canaparo, Giovanni Di Perri, and et al. 2019. "Correlation between Thiopurine S-Methyltransferase Genotype and Adverse Events in Inflammatory Bowel Disease Patients" Medicina 55, no. 8: 441. https://doi.org/10.3390/medicina55080441

Ribaldone, D. G., Adriani, A., Caviglia, G. P., De Nicolò, A., Agnesod, D., Simiele, M., Riganò, D., Pellicano, R., Canaparo, R., Di Perri, G., D’Avolio, A., Luzza, F., Abenavoli, L., Saracco, G. M., & Astegiano, M. (2019). Correlation between Thiopurine S-Methyltransferase Genotype and Adverse Events in Inflammatory Bowel Disease Patients. Medicina, 55(8), 441. https://doi.org/10.3390/medicina55080441